Medline Inc.
MDLN
$34.05
-$0.64-1.85%
NASDAQ
| 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.69B | 7.35B | 7.79B | 7.12B | 6.89B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.69B | 7.35B | 7.79B | 7.12B | 6.89B |
| Cost of Revenue | 5.47B | 5.51B | 5.87B | 5.24B | 4.98B |
| Gross Profit | 2.22B | 1.84B | 1.91B | 1.88B | 1.91B |
| SG&A Expenses | 1.30B | 1.23B | 1.27B | 1.12B | 1.09B |
| Depreciation & Amortization | 177.00M | 176.00M | 176.00M | 177.00M | 176.00M |
| Other Operating Expenses | 348.00M | 15.00M | 30.00M | 8.00M | 14.00M |
| Total Operating Expenses | 7.29B | 6.93B | 7.34B | 6.54B | 6.26B |
| Operating Income | 395.00M | 422.00M | 443.00M | 574.00M | 629.00M |
| Income Before Tax | 235.00M | 291.00M | 206.00M | 345.00M | 359.00M |
| Income Tax Expenses | 96.00M | 52.00M | 26.00M | 23.00M | 26.00M |
| Earnings from Continuing Operations | 139.00M | 239.00M | 180.00M | 322.00M | 333.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -79.00M | -110.00M | 2.00M | -- | -- |
| Net Income | 60.00M | 129.00M | 182.00M | 322.00M | 333.00M |
| EBIT | 395.00M | 422.00M | 443.00M | 574.00M | 629.00M |
| EBITDA | 651.00M | 676.00M | 704.00M | 827.00M | 879.00M |
| EPS Basic | 0.07 | 0.17 | 0.22 | 0.02 | 0.02 |
| Normalized Basic EPS | 0.08 | 0.09 | 0.22 | 0.01 | 0.01 |
| EPS Diluted | 0.07 | 0.16 | 0.22 | 0.02 | 0.02 |
| Normalized Diluted EPS | 0.08 | 0.09 | 0.22 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 856.67M | 819.93M | 810.00M | 17.48B | 17.50B |
| Average Diluted Shares Outstanding | 860.89M | 824.87M | 810.00M | 17.48B | 17.50B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | 52.75% | 36.96% | 90.99% |